RE: AVO18 Jan 2023 16:12
I agree that this was a well written and comprehensive update. Nothing hidden with details given on all aspects of the business.
iWantThatOne: The reason that certification is expected in H1 2024, is because (for CE marking) they have to test the system with a number of patients. That is going to take up most of this year, after which they need to feed those results into their CE documentation package and then have it reviewed and approved by a Notified Body. Its just what this is going to take timeline wise.
But, its not made clear if this is the case for both CE Marking AND the FDA 510K for the United States. I know it is required this way for the CE marking. But its not clear to me if it also is for the 510K, as that is handled differently in some ways compared to the CE process.
Overall I'm strongly tempted to add another few hundred thousand share to my holding. Its not lost on me that the long term share incentive plan has the senior staff vesting significant numbers shares once the share price is up over £1 per share (I believe for over 90 days, plus some other targets). I'm sure that they are going to move heaven and earth to get there. And, I suspect that consequently any takeover offer would need to minimally be at this price level, a market cap of £700M if we assume an additional 30% dilution from here through the issue of new shares and exercise of warrants.
I think this is the make or break year for AVO. And, I'm expecting them to make it, with multiple news coming through as they progress through the months ahead.
Bill